Sage Journals: Discover world-class research

Free access

Research article

First published 2012-4

Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes

Stephen J Nicholls, Kiyoko Uno

Diabetes & Vascular Disease Research

Free access

Research article

First published 2009-10

Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar,a γ-Dominant PPAR α/γ Agonist

Gerald G. Long, Vincent L. Reynolds, L. Wayne Dochterman [...]

Toxicologic Pathology

Retricted access

Research article

First published 2008-02

Rosiglitazone and 15-Deoxy-Δ 12,14 -Prostaglandin J 2,PPAR γ Agonists,Differentially Regulate Cigarette Smoke-Mediated Pro-Inflammatory Cytokine Release in Monocytes/Macrophages

Samuel Caito, Se-Ran Yang, Aruna Kode [...]

Antioxidants & Redox Signaling

Free access

Research article

First published 2008-2

Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar,a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event

Gerald G. Long, Vincent L. Reynolds, Alric Lopez-Martinez [...]

Toxicologic Pathology

Retricted access

Research article

First published 2012-7

PPAR γ Agonists and the Future for Insulin Sensitizers

Robert R Henry, Deborah Erickson, Theodore P. Ciaraldi

The British Journal of Diabetes & Vascular Disease

Free access

Review article

First published 2002-06

Vascular Effects of GI262570X (PPAR-γ agonist) in the Brown Adipose Tissue of Han Wistar Rats: A Review of 1-month,13-week,27-week and 2-year Oral Toxicity Studies

Chandikumar S. Elangbam, Thomas A. Brodie, H. Roger Brown [...]

Toxicologic Pathology

Free access

Research article

First published 2010-2

The PPAR-γ Agonist,Darglitazone,Restores Acute Inflammatory Responses to Cerebral Hypoxia–Ischemia in the Diabetic ob/ob Mouse

Rashmi Kumari, Lisa B Willing, Shyama D Patel [...]

Journal of Cerebral Blood Flow & Metabolism

Retricted access

Research article

First published 2004-1

Ppar-Γ Agonists Modulate Lipid Composition and Glomerulosclerosis in Zdf Diabetic Rats

N. Halaihel, B.L. Goldstein, T. Jiang [...]

Journal of Investigative Medicine

Retricted access

Other

First published 2006-09

Effects of the PPAR-γ Agonist Rosiglitazone on Renal Haemodynamics and the Renin-Angiotensin System in Diabetes

M Cecilia Lansang, Caroline Coletti, Sofia Ahmed [...]

Journal of the Renin-Angiotensin-Aldosterone System

Retricted access

Research article

First published 2006-5

Effect of Peroxisome Proliferator Activated Receptor (PPAR)γ agonists on prostaglandins cascade in joint cells

David Moulin, Paul-Emile Poleni, Mélanie Kirchmeyer [...]

Biorheology

Search results